Level C· Early human research exploring benefitsCohort StudyPubMed

Novel Role of Human Epicardial Adipocyte-Derived SPARCL1 in Postoperative Atrial Fibrillation Following Cardiovascular Surgery.

Harada T., Kondo H., Takahashi M., Yamasaki H., Takano M., Sato H.

Cohort Study with a reported sample of 274 on Cardiovascular Disease, published in JACC Clin Electrophysiol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
JACC Clin Electrophysiol (2025)
Country
United States
Reported sample size
274
Source database
PubMed
PMID
40608034
DOI
10.1016/j.jacep.2025.05.008

Abstract (original English)

Postoperative atrial fibrillation (POAF) is associated with short- and long-term morbidity and mortality. However, the ability of the epicardial adipocyte to regulate POAF remains poorly understood. The authors investigated the possible role of human epicardial adipocyte-derived adipokines in the regulation of the myocardial redox state and POAF. The authors prospectively studied 274 patients who underwent scheduled open-heart surgery. Finally, 149 patients without known atrial fibrillation were enrolled and divided into POAF and non-POAF groups. Epicardial adipose tissue biopsies and isolated preadipocytes were used to explore the important secretable adipokines associated with POAF. POAF occurred in 53 (35.6%) patients. Genome-wide expression profiling of background-matched differentiated preadipocytes representing the POAF or non-POAF groups and quantitative polymerase chain reaction validation as a biological replicate using all cohort samples revealed that only SPARCL1 was significantly downregulated in the POAF group. SPARCL1 messenger RNA expression in differentiated preadipocytes correlated with SPARCL1 protein concentration in the preadipocyte culture medium. SPARCL1 attenuated angiotensin II-induced oxidative stress in neonatal rat myocytes. Coculture of human induced pluripotent stem cell-derived atrial cardiomyocyte with the differentiated preadipocyte revealed that

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansAtrial FibrillationMaleAdipocytesPericardiumFemaleCalcium-Binding ProteinsMiddle AgedPostoperative ComplicationsCardiac Surgical Procedures

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research